The beneficial effects of oral nifedipine on cyclosporin-treated renal transplant recipients - a randomised prospective study

Transplant International

Volumn 9, Issue 2, 1996, Pages 115-125

  Harper, Steven J ^a   Moorhouse, Jennifer ^a   Abrams, Keith ^b   Jurewicz, Adam ^c   Nicholson, Michael ^a   Horsburgh, Terry ^a   Harris, Kevin ^a   Combe, Christian ^a   Bell, Peter R F ^a   Walls, John ^a   Donnelly, Peter K ^a   Veitch, Peter S ^a   Feehally, John ^a  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c WALSGRAVE HOSPITAL   (United Kingdom)

Author keywords

CyA, nifedipine, renal transplantation; Nifedipine, CyA, renal transplantation; Renal transplantation, nifedipine, CyA

Indexed keywords

ATENOLOL; AZATHIOPRINE; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN A; DOXAZOSIN; FUROSEMIDE; IMMUNOSUPPRESSIVE AGENT; MINOXIDIL; NIFEDIPINE; PREDNISOLONE;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ADULT; CALCIUM CHANNEL BLOCKERS; CREATININE; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HEMODYNAMIC PROCESSES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MIDDLE AGED; NIFEDIPINE; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 9044225533     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00336388     Document Type: Article

References (53)

1. Almond PS, Matas A, Gillingham K, Dunn DL, Payne WD, Gores P, Gruessner R, Najarian JS (1993) Risk factors for chronic rejection in renal allograft recipients. Transplantation 55: 752-757
2. Altman DG (1992) Practical statistics for medical research. Chapman and Hall, London, p 430
3. Basadonna GP, Matas AJ, Gillingham KJ, Payne WD, Dunn DL, Sutherland DER, Gores PF, Gruessner RWG, Najarian JS (1993) Early versus late acute renal allograft rejection: impact on chronic rejection. Transplantation 55: 993-995
4. Bia MJ, Tyler K (1991) Evidence that calcium channel blockade prevents cyclosporin-induced exacerbation of renal ischaemic injury. Transplantation 51: 293-295
5. Brinker KR, Dickerman RM, Gonwa TA, Hull AR, Langley JW, Long DL, Nesser DA, Trevino G, Velez RL, Vergne-Marini PJ (1990) A randomised trial comparing double-drug and triple-drug therapy in primary cadaveric renal tranplants. Transplantation 50: 43-49
6. Canadian Multicentre Transplant Study Group (1986) A randomised clinical trial of cyclosporine in cadaveric renal transplantation at three years. N Engl J Med 314: 1219-1225
7. Capasso G, Rosati C, Ciani F, Giordano DR, Russo F, De Santo NG (1990) The beneficial effect of atrial natriuretic peptide on cyclosporine nephrotoxicity. Am J Hypertens 3: 204-210
8. Carmellini M, Romagnoli J, Pietrabissa A, Di Stefano R, Oleggini M, Rindi P, Rizzo G, Mosca F (1994) Double-therapy vs triple therapy immunosuppression in cadaveric renal transplants. Transplant Proc 26: 2546-2547
9. Cheung JY, Bonventre JV, Malis CD, Leaf A (1986) Calcium and ischemic injury. N Engl J Med 314: 1670-1676
10. Dawidson I, Rooth P, Alway C, Dulzo T, Palmer B, Lu C, Peters P, Sagalowsky A, Sandor Z (1990) Verapamil prevents post transplant delayed function and cyclosporin A nephrotoxicity. Transplant Proc 22: 1379-1380
11. Dierperink H, Leysacc PP, Starklint H, Jorgensen KA, Kemp E (1986) Antagonist capacities of nifedipine, captopril, phenoxybenzamine, prostacyclin and indomethecin on cyclosporin A induced impairment of the rat renal function. Eur J Clin Invest 16: 540-548
12. European Multicentre Trial Group (1987) Cyclosporine in cadaveric renal transplantation: 5-year follow-up of a multicentre trial. Lancet II:506-7
13. Feehally J, Walls J, Mistry N, Horsburgh T, Taylor J, Veitch PS, Bell PRF (1987) Does nifedipine ameliorate cyclosporin A nephrotoxicity? Br Med J 295: 310
14. Ferguson CJ, Hillis AN, Williams JD, Griffin PJA, Salaman JR (1990) Calcium channel blockers and other factors influencing delayed function in renal allografts, Nephrol Dial Transplant 5: 816-818
15. Flechner SM, Van Buren CT, Kerman R, Kahan BD (1983) The effect of conversion from cyclosporine to azathioprine immunosuppression for intractable nephrotoxicity. Transplant Proc 15 [Suppl]:2869-2873
16. Greene WC, Parker CM, Parker CW (1976) Calcium and lymphocyte activation. Cell Immunol 25: 74-89
17. Gulaniker AC, MacDonald AS, Sungurrtekin U, Belitsky P (1992) The incidence and impact of early rejection episodes on graft outcome in recipients of first cadaver kidney transplants. Transplantation 53: 323-328
18. Harper SJ, Moorhouse J, Veitch PS, Bell PRF, Hosburgh T, Walls J, Donnelly PK, Feehally J (1992) Improved immediate graft function with nifedipine in cyclosporin A treated renal allograft recipients - a randomised prospective study. Transplantation 54: 742-743
19. Harper SJ, Moorhouse J, Veitch PS, Hosburgh T, Walls J, Bell PRF, Donnelly PK, Feehally J (1992) Nifedipine improves immediate, six and twelve month graft function in cyclosporin A (CyA) treated renal allograft recipients. Transpl Int 5 [Suppl 1]:69-72
20. Hauser AC, Derfler K, Stockenhuber F, Wamser P, Manosi L, Balcke P (1991) Effect of calcium-channel blockers on renal function in renal graft recipients treated with cyclosporine. N Engl J Med 324: 1517
21. Homan van der Heide JJ, Bilo HJG, Tegzess AM, Donker AJM (1990) The effects of dietary supplementation with fish oil on renal function in cyclosporine-treated renal allograft transplant recipients. Transplantation 49: 523-527
22. Kahan BD (1989) Cyclosporine. N Engl J Med 321: 1725-1738
23. Kiberd BA (1989) Cyclosporine-induced renal dysfunction in human renal allograft recipients. Transplantation 48: 965-969
24. Kirk AJB, Omar I, Dark JH (1990) Long-term improvement in renal function using nifedipine in cyclosporine-associated hypertension. Transplantation 50: 1061
25. Lindholm A, Albrechsten D, Tufveson G, Karlberg I, Persson NH, Groth C-G (1992) A randomised trial of cyclosporine and prednisolone versus cyclosporine, azathioprine and prednisolone in primary cadaveric renal transplantation. Transplantation 54: 624-631
26. Lindholm A, Ohlman S, Albrechtsen D, Tufveson G, Persson H, Persson NH (1993) The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplants treated by 3 cyclosporine regimens. Transplantation 56: 307-315
27. Loutzenhiser R, Epstein M (1987) Modification of the renal haemodynamic response to vasoconstrictors by calcium antagonists. Am J Nephrol 7 [Suppl 1]:7-16
28. Matthews JNS, Altman DG, Campbell MJ, Royston P (1990) Analysis of serial measurements in medical research. BMJ 300: 230-235
29. McCulloch TA, Harper SJ, Donnelly PK, Moorhouse J, Bell PRF, Walls J, Feehally J, Furness PN (1994) Influence of nifedipine on interstitial fibrosis in renal transplant allografts treated with cyclosporin A. J Clin Pathol 47: 839-842
30. McGiffen DC, Kirklin JK, Naftel DC (1985) Acute renal failure after heart transplantation and cyclosporine therapy. Heart Transplant 4: 396
31. McNally P, Mistry N, Idle J, Walls J, Feehally J (1989) Calcium channel blockers and cyclosporin metabolism. Transplantation 48: 1071
32. McNally PG, Baker F, Mistry N, Walls J, Feehally J (1990) Effect of nifedipine on renal haemodynamics in an animal model of cyclosporin A nephrotoxicity. Clin Sci 79: 259-266
33. McNally PG, Walls J, Feehally J (1990) The effect of nifedipine on renal function in normotensive cyclosporin A-treated renal allograft recipients. Nephrol Dial Transplant 5: 962-968
34. McNally P, Feehally J (1992) Pathophysiology of cyclosporin A nephrotoxicity: experimental and clinical observations. Nephrol Dial Transplant 7: 791-804
35. Mihatsch MJ, Thiel G, Ryffel B (1988) Morphologic diagnosis of cyclosporine toxicity. Semin Diagn Pathol 5: 104-121
36. Mobb G, Whiting PH, Feehally J, Veitch PS, Bell PRF (1991) The effect of the thromboxane receptor antagonist GR 32191B on cyclosporine-induced nephrotoxicity. Transplant Proc 23: 1241-1243
37. Morales JM, Rodriguez-Paternina E, Araque A, Hernandez E, Ruilope LM, Rodicio JL (1994) Long-term protective effect of a calcium antagonist on renal function in hypertensive renal transplant patients on cyclosporine therapy: a 5-year prospective randomized study. Transplant Proc 26: 2598-2599
38. 1 analogue misoprostol in renal transplant recipients treated with cyclosporine and prednisolone. N Engl J Med 322: 1183-1188
39. Myers BD (1986) Cyclosporine nephrotoxicity. Kidney Int 30: 964-974
40. Myers BD, Ross J, Newton L, Luetscher J, Perlroth M (1984) Cyclosporine-associated chronic nephropathy. N Engl J Med 311: 699-705
41. Neild GH, Reuben R, Hartley RB, Cameron JS (1985) Glomerular thrombi in renal allografts associated with cyclosporin treatment. J Clin Pathol 38: 253-258
42. Nussenblatt RB, Austin HA, Palestine AG, Preuss HG (1986) Hydergine and cyclosporine nephrotoxicity. Lancet I:1220-1221
43. Palmer B, Dawidson I, Sagalowsky A, Lu C (1990) Calcium channel blockers improve the outcome of cadaver renal transplantation. J Am Soc Nephrol 1: 767
44. Ponticelli C, Tarantino A, Montagnino G, Aroldi A, Banfi G, De Vecchi A, Zubani R, Berardinelli L, Vegato A (1988) A randomised trial comparing triple-drug and double-drug therapy in renal transplantation. Transplantation 45: 913-918
45. Powell-Jackson PR, Young B, Calne RY, Williams R (1983) Nephrotoxicity of parenterally administered cyclosporine after orthotopic liver transplantation. Transplantation 36: 505-509
46. Propper DJ, Whiting PH, Power DA, Edward N, Catto GRD (1989) The effect of nifedipine on graft function in renal allograft recipients treated with cyclosporin A. Clin Nephrol 36: 62-66
47. Siegal S, Castellan NJ (1989) Non parametric statistics for the behavioural sciences. McGraw-Hill International Editions, New York
48. Taburet AM, Singlas E, Colin J-N, Banzet O, Thibonnier M, Corvol P (1983) Pharmacokinetic studies of nifedipine tablet. Correlation with antihypertensive effects. Hypertension 5 [Suppl 2]:II29-II33
49. Taylor RJ, Lanranau MD, Makowka L, Rosenthal TJ, Gordon RD, Tzakis AG, Starzl TE, Hakala TR (1987) Cyclosporine immunosuppression and delayed graft function in 455 cadaveric renal transplants. Transplant Proc 19: 2100-2103
50. Van Buren D, Van Buren CT, Flechner SM, Maddox AM, Verrani R, Kahan BD (1985) De novo hemolytic uraemic syndrome in renal transplant recipients immunosuppressed with cyclosporine. Surgery 98: 54-62
51. Von Willebrand E, Hayry P (1983) Cyclosporin-A deposits in renal allografts. Lancet II:189-192
52. Wagner K, Albrecht S, Neumayer HH (1987) Influence of calcium antagonist diltiazem on delayed graft function in cadaveric kidney transplantation: results of a six month follow up. Transplant Proc 19: 1353-1357
53. Wagner K, Albrecht S, Neumayer HH (1987) Prevention of post transplant acute tubular necrosis by the calcium antagonist diltiazem: a prospective randimised study. Am J Nephrol 7: 287-291